These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15231038)

  • 1. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers.
    Parojcić J; Ethurić Z; Jovanović M; Ibrić S; Jovanović D
    J Pharm Pharmacol; 2004 Jun; 56(6):735-41. PubMed ID: 15231038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation.
    Parojcić J; Ibrić S; Djurić Z; Jovanović M; Corrigan OI
    Eur J Pharm Sci; 2007 Mar; 30(3-4):264-72. PubMed ID: 17188851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical characterization of sustained release matrix tablets based on novel carbomer polymers: formulation and in vivo investigation.
    Jelena P; Djurić Z; Jovanović M; Ibrić S; Kilibarda V; Jovanović D; Evic IK
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):99-104. PubMed ID: 16010868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
    Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
    Al-Zoubi NM; AlKhatib HS; Obeidat WM
    Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tablet disintegration and drug dissolution in viscous media: paracetamol IR tablets.
    Parojcić J; Vasiljević D; Ibrić S; Djurić Z
    Int J Pharm; 2008 May; 355(1-2):93-9. PubMed ID: 18226480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
    Obeidat WM; Nokhodchi A; Alkhatib H
    AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine.
    Royce A; Li S; Weaver M; Shah U
    J Control Release; 2004 May; 97(1):79-90. PubMed ID: 15147806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
    Xu X; Sun M; Zhi F; Hu Y
    Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro-in vivo correlation for nevirapine extended release tablets.
    Macha S; Yong CL; Darrington T; Davis MS; MacGregor TR; Castles M; Krill SL
    Biopharm Drug Dispos; 2009 Dec; 30(9):542-50. PubMed ID: 19876936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets.
    Gutiérrez-Sánchez PE; Hernández-León A; Villafuerte-Robles L
    Drug Dev Ind Pharm; 2008 Feb; 34(2):171-80. PubMed ID: 18302036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption.
    Dunne A; O'Hara T; Devane J
    Stat Med; 1999 Jul; 18(14):1865-76; discussion 1877. PubMed ID: 10407257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form.
    Souliman S; Blanquet S; Beyssac E; Cardot JM
    Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.